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a b s t r a c t
The biological and therapeutic responses to hyperthermia, when it is envisaged as an anti-tumor
treatment modality, are complex and variable. Heat delivery plays a critical role and is counteracted by
more or less efﬁcient body cooling, which is largely mediated by blood ﬂow. In the case of magnetically
mediated modality, the delivery of the magnetic particles, most often superparamagnetic iron oxide
nanoparticles (SPIONs), is also critically involved. We focus here on the magnetic characterization of two
injectable formulations able to gel in situ and entrap silica microparticles embedding SPIONs. These
formulationshave previously shown suitable syringeability and intratumoral distribution in vivo. Theﬁrst
formulation is based on alginate, and the second on a poly(ethylene-co-vinyl alcohol) (EVAL). Here we
investigated the magnetic properties and heating capacities in an alternating magnetic ﬁeld (141 kHz,
12 mT) for implants with increasing concentrations of magnetic microparticles. We found that the
magnetic properties of the magnetic microparticles were preserved using the formulation and in the wet
implant at 37 1C, as in vivo. Using two orthogonal methods, a common SLP (20 W g1) was found after
weighting by magnetic microparticle fraction, suggesting that both formulations are able to properly
carry the magnetic microparticles in situ while preserving their magnetic properties and heating
capacities.
& 2010 Elsevier B.V. All rights reserved.
1. Introduction
Induced hyperthermia is a recent therapeutic approach in
oncology protocols [1]. It consists of raising the temperature of a
target tissue or body region affected by local tumor lesions or even
heating the whole body in the case of extensively diffused cancer
lesions. These approaches are respectively called local, regional,
and whole-body hyperthermia [2]. Heat affects multiple and
complex biological processes, possibly leading to therapeutic
beneﬁts. The direct cell killing effect of heat is observed in vitro
for temperatures from 42 1C, which corresponds to a threshold for
cytotoxicity. Above 45 1C, tissues directly coagulate. Nonetheless,
in unfavorable metabolic microenvironments, such as those found
in some tumor areas, the threshold can be observed at lower
temperatures that are more easily achievable in clinical practice
[3–6]. Heat also modulates tumor blood ﬂow to varying extent and
sequence, either positively and/or negatively. The vascular
response of the tumor differs compared to basal blood ﬂow and
to the vascular response of normal tissue, leading to contrasting
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deleterious or beneﬁcial therapeutic effects [6,7]. High tumor blood
ﬂow impedes heating through high convective heat dissipation. In
contrast, low tumor blood ﬂow can favor heat deposition and
concentration due to low convection. This may lead to differential
bloodﬂowheat dissipation (decreased in tumorswhile increased in
the surrounding tissues) and a resulting rather selective heat
deposition in the tumor lesions [2]. The heat shock proteins, which
are crucial to the heat shock response, also present ambivalent
features [8]. On one hand, heat shock proteins may be associated
with some formof thermotolerance [9–12]. On the other hand, heat
shock proteins can also facilitate the unmasking of tumor antigens
and their presentation, thereby favoring the immune response to
cancer. These mechanisms induced by hyperthermia may thus
indirectly lead to an increased anti-tumor response [2,13–17]. In
clinical practice, hyperthermia is an accepted adjuvant to reference
therapies, mainly chemo- and radio-therapies [18–20]. In these
approaches, the physiological effects of heat such as the increased
blood supply and oxygen levels are decisive [7,21]. To improve
heating, numerous techniques have attempted to manipulate the
tumor physiology, among which embolization has been revealed
to be useful [4]. The technical limitations of the heat delivery and
the poor control of the heat dose are also crucial and impede the
effective distribution of cytotoxic temperatures and doses in the
target volume. Besides the various physicalmodalities of delivering
heat to solid tumors (infrared, ultrasound, microwave, and radio-
frequency techniques), the magnetically induced hyperthermia
modality is speciﬁcally based on heat dissipation through an
interaction with the magnetic component of an alternative mag-
netic ﬁeld [22,23]. This can be mediated by eddy currents, which
dissipate heat in a metallic stent. However, the drawback is that
this may lead to the adverse burning of the subcutaneous fat layer.
Heating induction can be further mediated by the magnetic
relaxations of so-called magnetic seeds [24]. Even at locations
deepwithin the body, tissue areas enclosingmagnetic seeds can be
heated [25]. Two heating processes are possible. Large ferro- or
ferri-magnetic particles dissipate heat through hysteresis effects in
the form of domain wall motion, also called hysteresis losses
[25–27]. Superparamagnetic nanoparticles allow heating through
Brownian or Ne´elmagnetic relaxation [28–32]. As for the latter, the
negligible dipole–dipole magnetic interactions with coated parti-
cles (the coatings prevent surface interactions) allow for the safe
injection in human bodies without the risk of adverse aggregation
[33]. Regarding the biocompatibility, coated superparamagnetic
iron oxide nanoparticles (SPIONs) are approved for humanuse [34].
Entrapping SPIONs in silica microparticles leads to superparamag-
netic seeds with three advantages: (i) inter-particle coupling
through SPION–dipole interactions is avoided, (ii) intrinsic super-
paramagnetism, i.e., Ne´el relaxation, is favored, and (iii) the
rheological behavior of the microparticles incorporated into the
liquid formulations allows for high syringeability. We previously
developed formulations incorporating these (SPION)–silica com-
posite microparticles on the basis of embolizing formulations.
Although it is liquid before injection, the vehicle converts into a
solid matrix in the injected tissue, forming a so-called implant that
entraps the microparticles [35]. With this conﬁned in the solid
tumor, we can demonstrate the efﬁciency of heating in an animal
model and the potential for local hyperthermia associated with
such a formulation [36]. As formagnetically induced hyperthermia
modalities, heating primarily relies on the magnetic properties of
the injected materials. From a pharmaceutical standpoint, it is
important to ensure the preservation of the magnetic properties in
the ﬁnal implant as well as the heating capacity under an
alternating magnetic ﬁeld. In the present work, we therefore
characterized by means of a Superconducting Quantum Interfer-
ence Device magnetometer (SQUID) the static magnetic properties
of the SPION–silica composite microparticles and of the implants
formed under conditions mimicking the in vivo environment.
Heating capacity was measured through power losses under
alternating magnetic ﬁeld. These characterizations were per-
formed with increasing magnetic microparticle concentrations in
the implants.
We focused these investigations on two formulations that had
previously demonstrated high syringeability and proper intratu-
moral distribution, both being essential criteria for therapeutic use
[35]. One was based on alginate hydrogels that were cross-linked
by co-injectable Ca2+. The other formulation was based on a water
insoluble polymer (poly(ethylene-co-vinyl alcohol), EVAL) orga-
nogel, which forms in situ an implant through precipitation after
organic solvent exchange with water.
2. Experimental details
2.1. Magnetic microparticles
Silica micron-sized particles embedding SPIONs were synthe-
sized as previously described [37]. Brieﬂy, organic precursors of
silica and iron chloride were mixed. The sol–gel precipitation of
silica was triggered by soft heating. Then, iron oxide precipitation
was carried out, and the gel porosity helped the nucleation of iron
oxide in the expected magnetite phase, which was black. There-
after, a second heating at a higher critical temperature (800 1C)
ensured magnetite phase (black color bulk) oxidation to form the
ferrimagnetic maghemite phase (tetragonal cell unit, red-brown
color bulk), which could be considered as fully oxidized magnetite
(c.a. 2Fe3O4+0.5O2-3gFe2O3 [38]), while preserving maghemite
from further transformation into hematite (aFe2O3, rhombohedral
and canted ferromagnetic of red color bulk) [39]. The bulk
maghemite–silica composite matrix resulting from this process
was then ground to formmicroparticles. A ﬁrst coarse powder was
obtained by ballmilling. This coarse powderwas then submitted to
wet attrition to obtain a ﬁner powder made of microparticles.
Inspection of the resulting microparticles by eye and under
microscope showed a reddish-brown color, more reddish than
the bulk reference color, with respect to the color plates in Ref. [40].
With this reference, and further taking into account the variation in
color with particle size, the slightly reddish-brown color of our
powder likely excludes the possibility of magnetite. In contrast,
commercial samples made of a similar silica matrix containing
nanoscaled crystallites of magnetite (as conﬁrmed by X-ray) dis-
play a black color very close to the black color of bulk magnetite
[40]. These organoleptic characteristics likely exclude the possibi-
lity that our microparticles contain nanoscaled magnetite crystal-
lites. Finally, thismagnetic seed powder contained 19.6% iron oxide
by mass, as determined by redox titration after silica matrix
dissolution under acidic conditions.
2.2. Characterization methods
2.2.1. Pycnometry and size analysis by laser diffraction
We used a helium pycnometer Accupyc 1330 (Micromeritics,
Aachen, Germany) to determine the magnetic microparticle den-
sity and speciﬁc volume. Calibration and sample measurements
were performed in a high accuracy mode. The size distribution of
themicroparticle powder sample dispersed inwaterwasmeasured
by laser diffraction with a Mastersizer apparatus (Malvern, Wor-
cestershire, UK). We set the particle density to 2.39 (as previously
determined by pycnometry determination). The microparticle
refractive index (1.67) was calculated by the weight ponderation
of the refractive index of sol–gel silicamicrospheres (1.42 [41]) and
maghemite (2.69) that compose the particle. An imaginary part
(0.1) of the refractive index that corresponds to 10% absorptionwas
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set according to instrument guidelines, given the opaque brown
color of the raw powder sample by eye. The refractive index of the
dispersionmedium, i.e., water, was set at 1.33. The powder sample
was added under stirring in the module dedicated to wet sample
analysis, typically at 900 rpm, up to an opacity degree of about 20%
(corresponding volume concentration of 0.014%).
2.2.2. X-ray diffraction (XRD)
Samples were examined by XRD with a BRUKER D8 diffract-
ometer using cupper Ka1 radiation (l¼1.54056 A˚). Diffractograms
were recorded in the range of 10o2yo100 with a step of 0.0141,
and the total data collection time was approximately 12 h. Data
were analyzed using the FullProf Suite [42].
2.2.3. Transmission electronic microscopy (TEM)
Formvar-coated grids were made hydrophilic by residual gas
ionization.Magneticmicroparticles were suspended in water at 1%
w/V and vigorously shaken, and 5 mL were allowed to deposit on
the grid for 30 s before removing the excess of suspension. The
observations were performed using a Tecnai G2 TEM (FEI, The
Netherlands), with a LaB6 cathode, at 160 kV.
2.2.4. Scanning electron microscopy and energy-dispersive X-ray
spectroscopy (SEM–EDX)
Magnetic microparticles were coated by the sputter deposition
of gold under 0.05 mbar of argon for 5 min at a 10 mA current
intensity. The SEM was a LEO 438 (Zeiss Carl, France). The module
for EDX analysis was from Gloore Instrument AG (Switzerland).
2.3. Formulation preparation and in vitro implant formation
2.3.1. Liquid formulation preparations
2.3.1.1. Polymer solution preparations for the organogel formula-
tion. A poly(ethylene-co-vinyl alcohol) (EVAL E-105 B Europe,
Zwijndrecht, Belgium) with 44 mol% ethylene (ensuring ﬂex-
ibility), which is clinically used for embolization (Onyxs), was
dissolved at 8% w/V in dimethyl sulfoxide (DMSO, Acros Organics,
Basel, Switzerland) at 50 1C. The density was measured using
Mohr’s balance, d24 1CH2O,01C ¼ 1:11089. The magnetic composite silica
microparticles were suspended using vigorous vortexing and
sonication.
2.3.1.2. Polymer solution preparations for the hydrogel formula-
tion. Low viscosity sodium alginate (Fluka, Buchs, Switzerland,
100 to 200 mPa s for 1% aq., 65–75% glucuronic acid) was dissolved
in ultraﬁltrated water at 2% w/V. The density was measured
using Mohr’s balance at 23 1C, d23 1CH2O,0 1C ¼ 1:01775. The magnetic
composite silica microparticles were suspended using vigorous
vortexing and sonication.
2.3.1.3. Magnetic microparticle incorporation. Hydrogel and orga-
nogel formulations were labeled as H-xx and O-xx, respectively,
where the number xx refers to themass percentage of themagnetic
microparticles added to a given volume of liquid polymer solution,
i.e., 5, 10 20, 40, 60, 80, and 100% w/V. The mass fractions will
constantly be restated for clarity, but attention should be paid to
the system considered: liquid implant formulation before gelation
or wet implant after gelation.
2.3.2. In situ formation of implants
All implants were prepared in vitro, mimicking the in vivo
injection intended for the treatment of soft tissue solid tumors. The
syringe and the receiving ﬂask were weighted to quantify the
experimental variation and allow for reliable composition deter-
mination. For full settling, we let the implant rest for 5 h in the ﬂask
after injection. The hydrogel formulation based on alginate was
injected in a solution of CaCl2 (Fluka, Buchs, Switzerland) at 25 mM
in ultraﬁltrated water. This acceptably mimics the in vivo
co-injection, during which mixing with the ionic cross-linker
(Ca2+) solution occurs within the needle, not in situ. This allows
for a more accurate determination of the injected masses. The
organogel formulation was injected in water, allowing polymer
precipitation andmagnetic silicamicroparticle entrapment to form
in situ in the implant. A 27 G needle was used for microparticle
concentrations below 40% w/V, and a 19 G was used on reaching
this concentration. The uncertainty in the implant mass, measured
byweight loss of the syringe, in parallel with theweight gain of the
receiving ﬂask, was below 0.8% when comparing the mass of the
harvested soaked implant. The resulting in-situ-formed implants
were harvested, excess liquid was drained while preserving the
soaked state, and this was submitted for further magnetic char-
acterization after weighing.
2.4. Superconducting quantum interference device (SQUID)
Magnetic properties were characterized using a Superconduct-
ing Quantum Interference Device (SQUID), model MPMS2, Quan-
tumDesign, INC (SanDiego CA, USA).We investigated themagnetic
properties of the implants in a ﬁeld and temperature range relevant
for their clinical use at 310 K (matching physiologic body tem-
perature at 37 1C) and between –39.8 and 39.8 kA m1 (500 to
500 Oe), which may appear limited compared to other funda-
mental studies, but it more closely reﬂects the 0–9.55 A m1
(0–120 Oe) range that is acceptable for hyperthermia treatment.
Soaked implants were sealed in a sample holding tube so that
soaking was preserved. Control powder was sealed dry in a sample
holding tube. The details of the sample compositions are shown in
Table 1. The symmetry of theM–H loopwas adjusted by subtracting
X offset, corresponding to the remnant ﬁeld from themagnetic ﬁeld
strength (H). The diamagnetic background was deduced by divid-
ing the magnetization value (M) by the slope of the end region of
the curve showing no hysteresis.
2.5. Heating capacities under an alternative magnetic ﬁeld
2.5.1. Alternative magnetic ﬁeld (AMF) generation and thermometry
The ﬁeld generator (TIG 2.5, Hu¨ttinger Elektronik GmbH,
Freiburg, Germany) consisted of an alternating current generator
feeding the coil inductor (the internal and external diameters and
length of the horizontal coil were 54, 64, and 46 mm, respectively).
With a small pick-up coil calibrated using a teslameter, we found a
linear relationship between the magnetic ﬁeld amplitude at
141 kHz and the generator peak-to-peak voltage. The current
intensity was adjusted to impose the voltage corresponding to a
12 mT induction. The sample placed in a cylindrical plastic holder
(0.4 cm in diameter and 3 cm in height) was isolated from the
surroundings by a polystyrene foam chamber ﬁttedwithin the coil.
The surface temperature of the sample was monitored with a
ﬂuoroptic thermometer (Luxtron, Santa Clara CA, USA) using
200 mm diameter ﬁber optic probes. The device reported tempera-
tures once every second with a 0.1 1C accuracy. A one-point
calibration at 20.0 1C was performed. Data were acquired using
Physitemp software (Luxtron, Santa Clara CA, USA). The implants
were prepared as described in Section 2.3.2. With this, we
determined the speciﬁc loss power (SLP) by twomethods:Methods
A and B.
2.5.2. Method A of SLP determination
The wet implant was placed in an insulated tube. The thermo-
metric probewas inserted into the implant periphery. The tubewas
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placedwithin the coil for magnetic induction by AMF. Experiments
were performed in triplicate, except for H-40, for which only
duplication was realized. We switched on the generator at t¼0 s.
We recorded the temperature from t¼0 to at least t¼60 s. The
derivative of the temperature by time (1C/s) was smoothed by the
moving averaged widow method on ﬁve points. We then deter-
mined the maximum of this derivative occurring within the ﬁrst
20 s. This maximum was considered to be the best approximation
of the ‘‘adiabatic’’ speciﬁc heat losses of the boundary conditions.
We then calculated the corresponding heat rate. For this, we
neglected the polymer mass fraction within the wet sample (this
is already low in the formulation, and it decreases with increase
in magnetic microparticle fraction and after implant formation in
water, with a mean polymer mass fraction in wet implants of
0.3870.36%). We took into account the silica (SiO2) mass present
in the sample, as determined by injection weighing. Although
negligible at low concentrations such as 5% w/V, this fraction is of
increasing importance in concentrated formulations. In the same
way, we took into consideration the iron oxide (Fe2O3). Finally,
the most important constituent to contribute to the heat capacity
of the whole implant was the water (H2O) mass present in the
sample,whichwas determined by desiccation. The standard (i.e., at
25 1C) heat capacities in J K1  g1 were 0.739, 0.651, and 4.18 for
SiO2, Fe2O3, and H2O, respectively. Method A thus allowed us to
calculate the total heat production rate and the speciﬁc loss power
(SLP) as normalized to the weight of the iron oxide in W/g of
iron oxide.
2.5.3. Method B of SLP determination
This method was adapted from Bretcanu et al. [43]. It consisted
of placing the wet implant, formed in vitro as previously described
butwith an adapted size, into an insulated vial in contactwith 4 mL
of additional water. This vial was then placed in the coil of the AMF
inducer, to be submitted to a 2 min AMF induction. The initial
temperaturewas recorded. After the 2 min AMF induction, the ﬁnal
temperature was determined, with the vial rapidly shaken to
ensure a homogeneous heat distribution. This allowed us to
determine the DT of water during 2 min of heating by AMF
induction, which is relevant for the in vivo conditions, where the
solid tumor tissues can be approximated by certainwater volumes.
Here, because themajormass fraction in the system iswater,which
has the highest heat capacity, the other components of the implant
can be neglected for calorimetric considerations.
3. Results and discussion
3.1. Structural properties of the SPION–silica composite
microparticles
The densities of hematite, magnetite, and maghemite are 5.26,
5.18, and 4.87 g  cm3, respectively [39]. The density of the
particles determined by pycnometry was 2.39170.001 g  cm3,
i.e., a speciﬁc volume of 0.41870.002 cm3  g1. The powder
discharge density, i.e., the bulk powder speciﬁc volume, was
0.3329 g/cm3. This corresponds roughly to the intra- plus extra-
granular porosity of the discharged powder, i.e., the uncompressed
powder, of 84%.
3.1.1. Size distribution analysis by laser diffraction
The powder dispersion in the water analysis by laser diffraction
revealed a mean diameter Dv(0,5) of 23.6 mm and a partially
overlapping bimodal size distribution, as shown in Fig. 1. The
size distribution corresponding to the ﬁrst mode, which can be
considered as log-normal or normal, is characterized by a large
span and is centered around a volume diameter of 10 mm. The size
distribution corresponding to the second mode appears to be log-
normal, sharper, and centered on a volume diameter of 40 mm.
Accurate measurement requires rapid stirring above 900 rpm, i.e.,
well above the 300-rpm threshold at which sedimentation hinders
Fig. 1. Size distribution of our particle powder sample by laser diffraction in awater
dispersion. The stirring speed applied herewas 960 rpm. A lower stirring speedmay
hinder the second-mode population (centered at 40 m) by sedimentation of the
largest particles (see Section 3.1.1).
Table 1
Sample details concerning the magnetic characterization by SQUID.
Formulation Constituting
polymer in
the mother
solution
Polymer
mass fraction
in the mother
solution
Polymer mass
fraction in the
liquid
formulation
Magnetic
microparticle
mass fraction in
the liquid
formulation
Mean mass of the
liquid formulation
injected for
implantation (g)
Variation
between
weighs in
mass
percentage
Weight
of the
wet
implant
(g)
Weight of
the
desiccated
implant (g)
Mean DT
during 2-
min in
AMF (K)
Standard
variation of
DT during
2-min in
AMF (K)
O-05 EVAL 0.069 0.066 0.038 1.012 0.040 0.714 0.104 0.678 0.203
O-10 EVAL 0.069 0.064 0.079 1.041 0.019 0.753 0.140 1.350 0.346
O-20 EVAL 0.069 0.059 0.143 1.121 0.036 0.896 0.227 3.827 0.808
O-40 EVAL 0.069 0.052 0.248 1.237 0.016 1.083 0.370 5.956 0.501
O-60 EVAL 0.069 0.046 0.329 1.328 0.038 1.166 0.508 10.782 1.514
O-80 EVAL 0.069 0.042 0.392 0.635 0.063 0.579 0.276 6.249 1.323
O-100 EVAL 0.069 0.037 0.460 1.090 0.073 1.034 0.366 10.119 0.561
H-05 Alginate Na 0.020 0.019 0.042 0.950 0.105 0.722 0.058 0.761 0.351
H-10 Alginate Na 0.020 0.018 0.091 1.037 0.617 0.902 0.105 1.322 0.153
H-20 Alginate Na 0.020 0.017 0.152 0.553 0.887 0.504 0.095 1.142 0.602
H-40 Alginate Na 0.020 0.015 0.262 0.746 0.496 0.740 0.206 4.529 0.237
H-60 Alginate Na 0.020 0.013 0.348 1.211 0.025 1.331 0.427 8.215 0.462
H-80 Alginate Na 0.020 0.012 0.417 1.048 0.114 1.147 0.435 9.639 0.964
H-100 Alginate Na 0.020 0.011 0.477 0.796 0.000 0.870 0.538 10.430 1.408
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the 40-mm mode subpopulation. This bimodal distribution likely
results from the two-step attrition processes of the bulk composite
matrix, leading to these microparticles. The ﬁrst step, consisting of
milling, leads to particles with diameters corresponding to the
largestmode. The second step, awet attrition, reduces the resulting
coarse powder yield to the ﬁnest particles corresponding in
diameter to the ﬁrst observed mode.
3.1.2. Particle analysis by TEM
The observations of the magnetic microparticles by transmis-
sion electronmicroscopy are illustrated in Fig. 2. The silicamatrix is
of intermediary electrodensity. The areas of lowest electrodensity
correspond to voids, conﬁrming the previously discussed porosity
and suggesting themicroporosity, and partiallymesoporosity, well
known for the sol–gel preparation method. SPIONs of the highest
electrodensity appear to be trapped in the mesopores. This con-
ﬁrms the role for mesopores in controlling nucleation and growth
during subsequent thermal treatment.
3.1.3. Particle analysis by SEM–EDX
High-magniﬁcation observations of a powder sample of mag-
netic microparticles by scanning electron microscopy are illu-
strated in Fig. 3. One-micrometer microparticles can be discerned.
These microparticles tend to aggregate in the dry powder sample.
The larger rough structures, c.a. 10 mm, are likely reversible
aggregates of microparticles. These reversible aggregates could,
to some extent, widen the volume diameter distribution of the
ﬁrst-modeparticle subpopulation observed by laser diffraction size
analysis. In contrast, the smooth larger structures with regular
edges (c.a. 10 mm) could correspond to subsisting milled particles,
as already evoked above. With regard to particle size, one should
keep in mind that energy-dispersive X-ray spectroscopy, EDX,
allows for the analysis of the electronic transition occurring after
incident electrons have interacted with the atoms of the sample
(roughly 1 mm in depth from the sample surface) and caused an
atom electron to be ejected. When an electron of the K-layer is
ejected, an electron of the L-layer replaces this electron and
produces a Ka-X-ray that is speciﬁc to the atom. The calculation
of the iron oxide content based on the hypothesis of sole Fe2O3 and
SiO2 compounds leads, for a representative point, to an iron oxide
proportion of 23.770.1%, close to that found by redox titration
(19.6%). Other points revealed highly oxidized compounds that
could not be analyzed.
3.1.4. Crystalline structure by XRD
The X-ray powder diffractogram of magnetic microparticles is
shown in Fig. 4. The rise in intensity at small angle (from 2y values
of 10–25 1C) is typical of the amorphous silica phase. Analyzing the
Bragg position of the reﬂexions, two structural models for FexOy
could ﬁt the obtained data:magnetite andmaghemite. Because the
crystallinity of the present sample does not reach the large levels of
bulk samples, Rietveld reﬁnement performed with both structural
types cannot be determined with certainty, which model is the
correct one, even if the maghemite one ﬁts slightly better (Fig. 4).
Of note, the peak intensity is relatively low and appears limited
compared to the background with respect to bulk maghemite. This
could be ascribed to the nanometric scale of the maghemite
crystallites within the silica matrix. This could also partly be
explained by the presence of a fraction of amorphous iron oxide
phase, which is probably limited to the surface layer at the
boundary of the crystallite lattice.
3.1.5. Magnetic properties by SQUID
The measurement of bulk magnetic microparticle powder
samples gives the typical curve of a soft magnetic material
displayed in Fig. 5 [44], with low coercivity (HC273.7 A m1 or
3.44 Oe) and retentivity (BR1.2101 A m2 kg1 or emu per
gram) of the magnetic seeds. Of note, in the case of soft magnetic
materials, the difference between the intrinsic coercivity and the
Fig. 2. Transmission electron microphotograph of magnetic microparticles used as
magnetic seeds for heating under AMF. The microparticles consist of SPIONs of high
electrodensity (dark spots) entrapped in a silicamatrix of lower electrodensity (gray
areas surrounding the dark spots). The lightest gray areas correspond to voids.
Fig. 3. SEM image illustrating the characteristics of the magnetic seed powder
samples prepared by milling bulk nancomposite and magnetic matrix followed by
wet attrition. The arrows indicate two particles of the most numerous subpopula-
tions with diameters in the range of 1 mm, as expected from the last step of wet
attrition. These microparticles agglomerate into larger rough structures with sizes
ranging from5 to 10 mm(#mark). These aggregates are likely reversible and are not
expected to be found after dispersion in liquids, which notably contain polymers
able to act as surfactants. The star marks indicate large structures with largest
dimensions of 5–10 mm but with smooth facets and regular edges by contrast.
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coercivity is negligible. Also, the gray dashed straight line in Fig. 5
reﬂects the slope of the curve after hysteresis closure. This slope is
classically describedwhen saturation is reachedduring ahysteresis
measurement, i.e., for a major hysteresis curve. For large magnetic
ﬁelds, the hysteresis closes, and the magnetic induction, B, and the
magnetization,M, are saturated (the saturation induction BS should
be distinguished from saturation magnetization MS). M is thus
constant. The linear increase in the induction, B, is then explained
as the partial conversion of the magnetic ﬁeld H into B. Never-
theless, because of the superparamagnetic behavior and with
regards to the literature, it is worth pointing out the possibility
that saturation is not effectively reached here and considering that
such characteristics can be displayed byminor hysteresis curves in
this speciﬁc case. Classically, the slope of dB/dH¼mrm0¼m tends
beyond BS toward m0 in SI units or 1 in S units, as the permeability
m(CGS) or mr(SI) approaches unity as H approaches inﬁnity. How-
ever, the slope of the line beyond hysteresis closure does not
normally appear to be unity because the B and H scales are quite
different [38]. Permeability can be evaluated in our case to have a
value of 0.32/kg ofmagnetic seeds in the SI systemor 3.87103/g
ofmagnetic seeds in the CGS system. Furthermore, in our case, both
the diamagnetic silica matrix and the paramagnetic contributions
of the iron oxide phase itself could contribute to the signal. We
opted for the deduction in this permeability component to focus on
the intrinsic induction (also called ferric induction) of themagnetic
microparticles and to attainM. This results in the dashed hysteresis
loop of Fig. 5. This procedure does not change BR (andMR) and only
raises the value of the still very low coercive ﬁeld to 307 A m1
(3.86 Oe). In themodel of fundamental studies butwith respect to a
muchmore limitedﬁeld range, this hysteresis loop thus evidences a
saturation of the ferrimagnetic phase, apparently at a ﬁeld larger
than 23.9 kA m1 (300 Oe). It is ﬁrst important to note that
saturation will thus never be reached in the clinical range of
0–9.5 kA m1 (0–120 Oe) for the AMF induction of hyperthermia.
The apparent saturation associates with a maximal intrinsic
induction (corresponding to the so-calledmagnetization at satura-
tion, ss, when the saturation is ascertained) of about 2.5 A m2/kg of
magnetic seeds (or 2.5 emu/g of magnetic seeds), which translates
to 12.8 A m2/kg of iron oxide. These values for materials with
particular micro- and nano-structures are classically compared
with the reference experimental values for bulk materials to ﬁnd
a landmark (i.e., for maghemite: 4159 kA m1 (2000 Oe) for the
saturation ﬁeld, and sS¼60–80 A m2/kg of bulk maghemite at
300 K [40]). This comparison is only indicative and should be
cautiously criticized in the case of complex microstructures. It is
known that the saturation magnetization is highly dependent
on magnetic particle interactions with the matrix in the case
of composite materials and on magnetic particle concentrations
Fig. 4. X-ray powder diffraction characterization. The observed intensity of
diffraction by the magnetic microparticle powder is depicted by the open light
gray open circled dots (upper). The diffractogram calculated using the Rietveld
reﬁnement for maghemite with Fullprof [42] is superimposed as the continuous
black line. Reference 2y values corresponding to the Bragg diffraction rays for
maghemite are displayed as dark gray vertical bars below (middle). The difference
between the observed and calculated values of diffraction intensity is displayed
below in the lighter gray line.
Fig. 5. Magnetization curve of raw magnetic microparticles, control sample c, as determined by the SQUID loop measurement, characteristics of the superparamagnetic
behavior (sample mass of 8 mg). The directly obtained curve is depicted by a continuous black line. Shown by a straight dashed gray line are the paramagnetic contributions
thatwere calculated. The dashedblack line corresponds to the curve after the deduction of these paramagnetic contributions. The inset on the bottomright details these curves
at small magnetic induction, as well as the offset applied to compensate for the small remnant ﬁeld within this range. This reveals a very small hysteresis, characteristic of a
largely superparamagnetic population of particles with a very low proportion of particles that are still blocked.
P.-E. Le Renard et al. / Journal of Magnetism and Magnetic Materials 323 (2011) 1054–1063 1059
Author's personal copy
within the matrix, concentrations which govern the interactions
and coupling between particles [45,46]. In our case, the iron
oxide concentration is relatively low and thus is not problematic.
Also, the speciﬁc saturation magnetization decreases notably with
increase in speciﬁc surface area [47] and is inﬂuenced by the
particle morphology [48]. The saturation magnetization of maghe-
mite nanoparticles embedded in a silica matrix was indeed
demonstrated to decrease drastically when the temperature
increased from 77 to 300 K [49]. Although not clearly understood,
this appears to be a consequence of the already-mentioned surface
effects, prominent at the nanoscale, due to the paramagnetic
external layer surrounding the ferrimagnetic core of the maghe-
mite nanoparticles, resulting in a decreased magnetic diameter
[50–52]. Because the magnetic moment is determined exclusively
by the ferrimagnetic core where the spins are aligned as a result of
the super-exchange interaction, the spontaneous magnetization
consequently decreases [49]. In comparison, the variation in the
saturation magnetization in bulk maghemite appears to be very
limited, a seven-fold factor less over the same temperature range
(the Curie point of maghemite, Tc, can be interpolated on the
order of 1123 K or 850 1C if it would not give prior temperature
decomposition [38]). It can thus be hypothesized that themagnetic
diameter and saturation induction of the present nanocomposite
magnetic seeds will be even lower at the investigated temperature
of 310 K. This most likely explains why the reported saturation
magnetization value of our maghemite nanocomposite particle is
lower than the value for bulkmaghemite. It isworth noting that the
temperature used in our experiments, 310 K, matching the phy-
siological body temperature (37 1C), is relatively high and is rarely
investigated. Regarding the susceptibility, attainable through the
initial rising part of the curve, i.e., the virgin curve of our hysteresis
loop measurement, we obtained a speciﬁc ‘‘intrinsic’’ mass sus-
ceptibility, wim¼3.8104/kg of magnetic seeds (in the SI system,
which in the CGS system gives 3.0102/g of magnetic seeds in
the implant by dividing by a conversion factor of 4p103), after
the deduction of the paramagnetic contributions (which represent
a mass ‘‘paramagnetic’’ susceptibility of 5105/kg of magnetic
seeds in SI, or 4103/g magnetic seeds in CGS). As previously
discussed, wim can be attributed to the iron oxide mass fraction,
leading ﬁnally to a susceptibility of 1.9103/kg of iron oxide in
the SI system (i.e., 0.15/g of iron oxide in the CGS system).
3.2. Magnetic properties of implants (SQUID)
The static magnetic properties of in-situ-formed implants based
on the two formulations, hydrogel (Alginate 2% w/V in water) or
organogel (EVAL 8% w/V in DMSO), with increasing magnetic
microparticle concentrations (whose compositions are detailed
in Table 1 with respect to the methodological approach detailed in
Section 2.3), appear to well correspond to the magnetic character-
istics of the control magnetic particles. The hysteresis loops of all
implants revealed similarities to those of the control sample (C),
suggesting the preservation of the superparamagnetic behavior of
microparticles in the implants formed in situ. It is important to note
that the curves were even more similar when the magnetization
values were weighted by the mass of constituting magnetic
microparticles (or iron oxide content) determined on the basis of
weighing the injections. This was not the case when the magne-
tization values were weighted by the masses of the wet implants
introduced in the SQUID. The magnetic characteristics of the
implants are summarized in Table 2, with respect to the magnetic
characteristics of the control powder. As previously evaluated,
the slope of dB/dH after hysteresis enclosure was deduced.
The calculated contributions to permeability per gram of wet
sample increased with the magnetic microparticle concentration,
reaching, for the formulation with the largest concentration of
magnetic microparticles (100%w/v), half of the valuemeasured for
the control powder of magnetic microparticles. This deserves
further comment. When looking at the weights of the injected
formulations and of the wet implants introduced in the SQUID, we
can exclude the effect of the alveolar water contained within the
spongious microstructure of the implants (implant water contents
ranged from 49% to 89%, as also detailed in [35]). The magnetic
effect of the polymer matrix should be considered, noting that the
low polymer fraction decreases when the calculated contributions
to permeability increase. It is likely that the matrix inﬁltrating
micropores or the layer surrounding the particles, whose thickness
decreases, would generate a permeability contribution opposed to
the permeability contributions observed for the control. On the
basis of an opposite contribution to permeability, one can also
describe close associations of one constituent of the formulation or
implant with the magnetic seeds of increasingmass fraction, likely
involving the smallest porosities. We hypothesize that water,
Table 2
Magnetic characteristics determined by SQUID.
Formulation Mass magnetic
susceptibility by kg of
sample as introduced in
SQUID (SI unit systems,
m3 kg1)
Deduced
contributions to
permeability per kg
of sample (SI unit
systems, m3 kg1)
Coercive
ﬁeld
(A m1)
Retentivity per unit
mass of constituting
magnetic seeds
(A m2 kg1 or
emu  g1)
Mass magnetic
susceptibility per
unit mass of
constituting magnetic
microparticles (SI unit
systems, m3 kg1)
Maximal magnetization
per unit mass of
constituting magnetic
seeds (A m2 kg1 or
emu  g1)
Hysteresis area per
unit mass of
constituting
magnetic
microparticles
(A m kg1)
O-05 3.01105 3.91106 248.933 0.11390 3.82104 2.9233 3638
O-10 5.66105 7.40106 239.543 0.11393 3.95104 3.0210 3669
O-20 9.02105 1.15105 238.120 0.11171 3.91104 3.0038 3606
O-40 1.38104 1.75105 253.278 0.11556 3.81104 2.8844 3602
O-60 1.59104 2.11105 266.589 0.11633 3.48104 2.7495 3654
O-80 1.68104 2.14105 259.233 0.10823 3.31104 2.6760 3480
O-100 1.82104 2.36105 246.423 0.10155 3.37104 2.5969 3533
H-05 3.32105 4.31106 237.135 0.10942 3.89104 2.9489 3602
H-10 4.71105 6.12106 227.949 0.10152 3.71104 2.8437 3156
H-20 7.52105 1.01105 264.785 0.10128 3.05104 2.4570 3254
H-40 1.30104 1.46105 301.299 0.11868 3.92104 2.5771 4172
H-60 1.35104 1.71105 262.669 0.10916 3.29104 2.6575 3469
H-80 1.67104 2.21105 255.879 0.10914 3.38104 2.6562 3518
H-100 1.75104 2.30105 263.956 0.11505 3.50104 2.7822 3830
C 4.28104 4.86105 307.428 0.11745 3.80104 2.6581 3776
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already present in the formulation for hydrogels or once precipi-
tated in water for organogels, plays a prominent role in easily
inﬁltrating the silica matrix and even the maghemite phase
porosity. With a lower volume susceptibility, inﬁltrated water
paramagnetism competes then with the silica diamagnetism.
Regarding the coercivity, it should be restated that this parameter
is only dependent on the microstructure and is related to the
anisotropy. Similarly to an ‘‘intensive’’ magnetic property, coerciv-
ity is independent of the iron concentration [53]. In our case, the
coercivity varied unpredictably for implants with increase in
magnetic seed concentrations, but it remained constantly lower
than or similar to the control powder. This indicates that
there are no crucial anisotropy variations. Retentivity was also
very comparable among the implants and control samples. The
mass magnetic susceptibility and saturation magnetization of the
implants were found here to be similar to those of control powder,
and this was very concordant with the amount of magnetic seeds
present in the implant. The hysteresis area (determined from
the curves weighted by the amount of magnetic seeds constituting
the implant) was reproducibly very constant. The small hysteresis
area allows us to conclude that hysteresis losses would not
signiﬁcantly contribute to heating in AMF. Therefore, in hydrogel
and organogel formulations forming in-situ implants, themagnetic
properties of nanocomposite iron oxide silica microparticles, on
which magnetically mediated hyperthermia in AMF relies, are
relatively preserved.
3.3. Heating capacities of implants under AMF
Wet implant preparation conditions for SLP determinations
were comparable to the conditions of preparation used for the
magnetic property characterizations, with both conditions similar
to the in vivo conditions. SLP was determined at 141 kHz and
12 mT, per gram of iron oxide composing the implants by the two
orthogonalmethods:Methods A andB (see Sections 2.5.2 and 2.5.3,
respectively). Of note, the sample characteristics and experimental
details can be found in Tables 3 and 4, for experimental Methods
A and B, respectively. Results obtained by Methods A and B are
gathered in Fig. 6. Taking all these results together and taking
Table 3
Sample details concerning Method A of SLP determination.
Formulation Constituting
polymer in
the mother
solution
Polymer
mass fraction
in themother
solution
Polymer mass
fraction in the
liquid
formulation
Magnetic
microparticle
mass fraction
in the liquid
formulation
Mean mass of the
liquid formulation
injected for
implantation (g)
Variation
between
weighs in
mass
percentage
Weight
of the
wet
implant
(g)
Weight of
the
desiccated
implant (g)
Mean
initial
implant
heating
rate (K/s)
Standard variation
of the measured
initial implant
heating rate (K/s)
O-05 EVAL 0.069 0.066 0.038 0.493 0.061 0.338 0.051 0.083 0.003
O-10 EVAL 0.069 0.064 0.079 0.569 0.105 0.456 0.080 0.158 0.099
O-20 EVAL 0.069 0.059 0.143 0.545 0.073 0.428 0.111 0.247 0.059
O-40 EVAL 0.069 0.052 0.248 0.521 0.019 0.423 0.155 0.317 0.049
O-60 EVAL 0.069 0.046 0.329 0.513 0.020 0.456 0.194 0.495 0.095
O-80 EVAL 0.069 0.042 0.392 0.559 0.161 0.512 0.240 0.646 0.046
O-100 EVAL 0.069 0.037 0.460 0.621 0.032 0.571 0.310 0.889 0.071
H-05 Alginate Na 0.020 0.019 0.042 0.390 0.333 0.259 0.023 0.085 0.023
H-10 Alginate Na 0.020 0.018 0.091 0.341 0.264 0.240 0.035 0.147 0.021
H-20 Alginate Na 0.020 0.017 0.152 0.457 1.226 0.429 0.078 0.250 0.014
H-40 Alginate Na 0.020 0.015 0.262 0.367 0.136 0.357 0.102 0.412 0.014
H-60 Alginate Na 0.020 0.013 0.348 0.392 0.281 0.407 0.143 0.509 0.039
H-80 Alginate Na 0.020 0.012 0.417 0.381 0.577 0.409 0.162 0.564 0.089
H-100 Alginate Na 0.020 0.011 0.477 0.434 0.092 0.438 0.186 0.663 0.042
Table 4
Sample details concerning Method B of SLP determination.
Formulation Constituting
polymer in
the mother
solution
Polymer mass
fraction in the
mother
solution
Polymer mass
fraction in the
liquid
formulation
Magnetic
microparticle mass
fraction in the
liquid formulation
Mean mass of the
liquid formulation
injected for
implantation (g)
Variation
between
weighs
in mass
percentage
Weight
of the
wet
implant
(g)
Weight
of the
desiccated
implant (g)
Mean DT
during
2 min in
AMF (K)
Standard
variation of
DT during
2 min in
AMF (K)
O-05 EVAL 0.069 0.066 0.038 1.012 0.040 0.714 0.104 0.678 0.203
O-10 EVAL 0.069 0.064 0.079 1.041 0.019 0.753 0.140 1.350 0.346
O-20 EVAL 0.069 0.059 0.143 1.121 0.036 0.896 0.227 3.827 0.808
O-40 EVAL 0.069 0.052 0.248 1.237 0.016 1.083 0.370 5.956 0.501
O-60 EVAL 0.069 0.046 0.329 1.328 0.038 1.166 0.508 10.782 1.514
O-80 EVAL 0.069 0.042 0.392 0.635 0.063 0.579 0.276 6.249 1.323
O-100 EVAL 0.069 0.037 0.460 1.090 0.073 1.034 0.366 10.119 0.561
H-05 Alginate Na 0.020 0.019 0.042 0.950 0.105 0.722 0.058 0.761 0.351
H-10 Alginate Na 0.020 0.018 0.091 1.037 0.617 0.902 0.105 1.322 0.153
H-20 Alginate Na 0.020 0.017 0.152 0.553 0.887 0.504 0.095 1.142 0.602
H-40 Alginate Na 0.020 0.015 0.262 0.746 0.496 0.740 0.206 4.529 0.237
H-60 Alginate Na 0.020 0.013 0.348 1.211 0.025 1.331 0.427 8.215 0.462
H-80 Alginate Na 0.020 0.012 0.417 1.048 0.114 1.147 0.435 9.639 0.964
H-100 Alginate Na 0.020 0.011 0.477 0.796 0.000 0.870 0.538 10.430 1.408
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variability in account, it appears that the intrinsic SLP associated
with magnetic seeds is preserved in the various implants studied
here, with the real intrinsic SLP value tending to be the SLP value
determined for the control particles, c.a. 20 W g1 of iron oxide.
From thepharmaceutical point of view, it should bementioned that
these formulations are also stable with regard to their magnetic
properties and heating capacities over large periods of storage, and
the limits of storage indeed rely on the loss of syringeability and
implant formation capacity of the formulations (data not shown).
With Method A, a short delay of a few seconds could be observed
after switching on the AMF inducer before seeing a temperature
increase. This delay could be attributed to the electromagnetic
stabilization of the inducer. It could also result from the initial
diffusion of heat in the implant (through thermal conductivity).
The heat conduction through the silicamatrix could be the limiting
step in this case. Interestingly, when comparing both methods of
SLP determination, it appears that Method A gives a poor precision
for the implants containing low magnetic microparticle concen-
trations and likely associates with an overestimation of SLP. In
contrast, Method B seems to be more precise at low magnetic
microparticle fractions, but, regarding accuracy, the SLP seems
underestimated in turn. For high magnetic microparticle concen-
trations, both methods appear to be relatively more accurate and
precise, converging toward the SLP of c.a. 20 W g1 of iron oxide
contained in the implant. This strongly supports the preservation of
the intrinsic SLP of themagneticmicroparticleswithin the implants
formed by both formulation types, even if slight differences can be
suggested when precisely considering the effect of the polymer
matrix. It is worth noting that with method B, the temperature
elevation in water reported as the meanDT in Table 4 gives an idea
of the tissue temperature that could be reached in the ideal
situation where no heat dissipation by convection or conduction
occurs. As mentioned in the introduction, the most important
parameter of heat dissipation is the blood ﬂow and its response
to heat under the pathophysiological conditions considered, which
can eventually lead to negligible tissue temperature elevation
in vivo. In this regard, it should be noted that both formulations
are also known to be embolizing agents capable of blocking
blood ﬂow in vascular or tumor lesions, mainly when injected
through intravascular routes but also when injected in solid
tumors. The embolizing characteristics could contribute to increase
the heating efﬁciency in situ and thereby increase the therapeutic
potential [36].
4. Conclusions
The superparamagnetic properties of magnetic silica composite
microparticles embedding nanoscaled maghemite iron oxides are
preserved in the injectable formulations for the whole range of
concentrations that allow syringeability. These properties also
remain preserved in the implants formed in situ.
The magnetic properties as well as the heating capacity, which
improved with increase in particle fraction, can be extrapolated
from the concentration of magnetic microparticles. With these
AMFparameters, a straightforward determination of the dissipated
heat is now possible. In association with the previous in vivo
studies, this further allows for the modeling of tissue heating
in vitro and in vivo, and this improves our understanding of the heat
delivery through formulations intended formagneticallymediated
hyperthermia in the treatment of solid tumors.
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